Edition:
United States

People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

131.39USD
22 Sep 2017
Change (% chg)

$-0.36 (-0.27%)
Prev Close
$131.75
Open
$131.99
Day's High
$132.39
Day's Low
$131.28
Volume
1,554,107
Avg. Vol
1,871,152
52-wk High
$137.07
52-wk Low
$109.32

McClellan, Mark 

Dr. Mark B. McClellan, M.D., Ph.D. is an Independent Director of Johnson & Johnson. Dr. McClellan became the inaugural Director of the Duke-Robert J. Margolis, MD, Center for Health Policy in January 2016, and the Margolis Professor of Business, Medicine and Policy at Duke University. He is also a faculty member at Dell Medical School at The University of Texas in Austin. Previously, he served from 2007 to 2015 as a Senior Fellow in Economic Studies, and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. Dr. McClellan served as Administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006, and as Commissioner of the U.S. Food and Drug Administration from 2002 to 2004. He served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House from 2001 to 2002, and during President Bill Clinton’s administration, held the position of Deputy Assistant Secretary for Economic Policy for the Department of the Treasury. Dr. McClellan previously served as an associate professor of economics and medicine with tenure at Stanford University, where he also directed the Program on Health Outcomes Research. Dr. McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the Food and Drug Administration, is a member of the National Academy of Medicine and chairs the Academy’s Leadership Consortium for Value and Science-Driven Health Care, and co-chairs the guiding committee of the Health Care Payment Learning and Action Network.

Basic Compensation

Total Annual Compensation, USD 110,000
Restricted Stock Awards, USD 164,985
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 274,985

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

26,871,700

Dominic Caruso

11,304,800

Peter Fasolo

3,621,280

Paulus Stoffels

12,725,500

Michael Ullmann

5,676,350

Joaquin Duato

10,104,500
As Of  31 Dec 2016